KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Goodwill (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 11 years of Goodwill data on record, last reported at $1.7 billion in Q4 2024.

  • For Q4 2024, Goodwill changed N/A year-over-year to $1.7 billion; the TTM value through Dec 2024 reached $1.7 billion, changed N/A, while the annual FY2024 figure was $1.7 billion, N/A changed from the prior year.
  • Goodwill reached $1.7 billion in Q4 2024 per JAZZ's latest filing, down from $1.7 billion in the prior quarter.
  • Across five years, Goodwill topped out at $1.7 billion in Q2 2024 and bottomed at $1.6 billion in Q3 2022.
  • Average Goodwill over 3 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
  • The widest YoY moves for Goodwill: up 7.08% in 2023, down 7.08% in 2023.
  • A 3-year view of Goodwill shows it stood at $1.6 billion in 2022, then rose by 7.08% to $1.7 billion in 2023, then rose by 0.65% to $1.7 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Goodwill were $1.7 billion in Q4 2024, $1.7 billion in Q2 2024, and $1.7 billion in Q3 2023.